Latest News and Press Releases

ROCKVILLE, Md., June 1, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Dr. Raafat Fahim, President and Chief Executive Officer, will present at Noble Financial...

ROCKVILLE, Md., May 6, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its first quarter financial results for the three month period ended March 27, 2010. The Company...

ROCKVILLE, Md., April 26, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its first quarter 2010 financial results on Thursday, May 6, 2010, after...

ROCKVILLE, Md., April 5, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that the European Patent Office (EPO) upheld the Company's opposition to European Patent No....

ROCKVILLE, Md., March 23, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that its Board of Directors has approved an aggregate total of up to $60.9 million to...

ROCKVILLE, Md., March 17, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced that it has initiated the second of two pivotal Phase III clinical trials for NicVAX® (Nicotine...

ROCKVILLE, Md., March 11, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that its 2010 Annual Meeting of Shareholders will be held on Thursday, May 20, 2010 at 10:00...

ROCKVILLE, Md., March 10, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced fourth quarter and year-end financial results for the three and twelve month periods ended...

ROCKVILLE, Md., March 8, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that the closing requirements set forth in the exclusive option and license agreement for...

ROCKVILLE, Md., March 5, 2010 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its 2009 fourth quarter and full-year financial results on Wednesday, March...